The King’s Speech: thin gruel or more than meets the eye?

Public Affairs

The King’s Speech: thin gruel or more than meets the eye?

This morning, several of the OVID team gathered around our meeting room table to watch the King’s Speech, setting out Labour’s initial programme for government. It’s fair to say that, at that first sight, the programme did not set our pulses racing. From a health perspective, there were positive noises about reducing waiting lists and

The Age of Starmer?

As the Labour Party met in Manchester, and listened to powerful and emotive stories from voters, including from a terminal cancer patient, Nathaniel, who wondered “what might have been” had he received cancer treatment on the NHS earlier, the Labour leader, Sir Keir Starmer, took to the stage to promise an end to “sticking plaster

General Election 2024: Soaked Sunak’s Surprise

On a drizzly day in May, a rain-soaked Prime Minster rather bravely, in all senses of the word, stepped outside Downing Street to announce a general election. Reverberating to the sounds of the iconic theme tune of Labour’s 1997 landslide victory, the Prime Minister referenced the NHS only once – in terms of the “record ...

Rare Disease Action Plan: What’s in store for 2024

There are 300 million people worldwide living with a rare condition. #RareDiseaseDay

Every year, on the last day of February, the global rare disease community comes together to raise awareness and advocate for positive change for the 300 million people worldwide living with a rare disease. To mark Rare Disease Day, the Department of Health and Social Care have published their third Rare Diseases Action Plan for

Labour’s Life Sciences Strategy – more of the same?

a small collection of pills

Whilst the date of the General Election is yet to be announced, both the Conservative and Labour Parties have started 2024 in full campaign mode. Long accused of having no real policies, the latest offering from Labour – a Life Sciences Sector Strategy announced today at an industry roundtable at the Stevenage Bioscience Catalyst –

Newborn Screening: the road to 2024

As we look forward to 2024, our Senior Account Executive, Robbie Lockyer, considers the outlook for newborn screening for rare diseases, and discusses whether the UK is will continue to fall behind our European neighbours.  Since the 1950s, when the newborn blood spot (NBS) screening programme was first introduced (commonly referred to as the heel prick

Let them eat cake: can France steal the UK’s life science crown?

This week President Macron launched Innovation Santé 2030 , Roudie Shafie, Partner at OVID Health, assesses how France really measures up to the UK when it comes to the life sciences eco-system.   President Macron’s recent announcement was the culmination of the last couple of years of design to define how the life sciences sector will

Contact.

OVID Health
Office 5.09
1 Lyric Square
London
W6 0NB

+44 (0) 330 111 0255
[email protected]

About.

We’re an award-winning specialist healthcare communications agency and founders of the Patient Advocacy & Centricity Tracker tool, as well as the global Patient Partnership Index.

The Health Change Makers.

OVID Health is a trading name of Ovid Consulting Ltd (Company No. 11372061)
registered in England at B19, SBC House, Restmor Way, Wallington, SM6 7AH.
Site by XYCO

OVID Health is a trading name of Ovid Consulting Ltd (Company No. 11372061)
registered in England at B19, SBC House, Restmor Way, Wallington, SM6 7AH.

Site by XYCO